| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 25.92× | 25.92× | 23.38× | 19.86× | 23.35× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.72× | 0.73× | 0.72× | 0.62× | 0.36× | ||
| 0.40× | 0.40× | 0.36× | 0.28× | 0.25× | ||
| 0.69× | 0.69× | 0.94× | −0.88× | 0.94× | ||
| 0.60× | 0.60× | 0.88× | −0.26× | 0.85× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 23.35 | 19.86 | 23.38 | 25.92 | 25.92 | |
| Working Capital Turnover | 0.36 | 0.62 | 0.72 | 0.73 | 0.72 | |
| Asset Turnover | 0.25 | 0.28 | 0.36 | 0.40 | 0.40 | |
| Cash Conversion (CFO/Net Income) | 0.94 | -0.88 | 0.94 | 0.69 | 0.69 | |
| CFO/EBITDA | 0.85 | -0.26 | 0.88 | 0.60 | 0.60 |